• Tenon Medical Inc TNON.OQ TNON.O is expected to show a rise in quarterly revenue when it reports results on March 10 (estimated) for the period ending December 31 2024

• The Los Gatos California-based company is expected to report a 79.5% increase in revenue to $1.451 million from $808 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Tenon Medical Inc is for a loss of $2.54 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Tenon Medical Inc is $10.00​, above​ its last closing price of $1.36. ​​​

This summary was machine generated March 7 at 11:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)